1 study found for:    21812672 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Intervention: Drug: Alemtuzumab (Campath)

Indicates status has not been verified in more than two years